A vulnerability-based approach to human-mobility reduction for countering COVID-19 transmission in London while considering local air quality

Manu Sasidharan; Ajit Singh; Mehran Eskandari Torbaghan; Ajith Kumar Parlikad

doi:10.1101/2020.04.13.20060798

Abstract

An ecologic analysis was conducted to explore the correlation between air pollution, and COVID-19 cases and fatality rates in London. The analysis demonstrated a strong correlation (R²>0.7) between increment in air pollution and an increase in the risk of COVID-19 transmission within London boroughs. Particularly, strong correlations (R²>0.72) between the risk of COVID-19 fatality and NO₂ and PM_2.5 pollution concentrations were also found. Although this study assumed the same level of air pollution across a particular London borough, it demonstrates the possibility to employ air pollution as an indicator to rapidly identify the city’s vulnerable regions. Such an approach can inform the decisions to suspend or reduce the operation of different public transport modes within a city. The methodology and learnings from the study can thus aid in public transport’s response to COVID-19 outbreak by adopting different levels of human-mobility reduction strategies based on the vulnerability of a given region.

One Sentence Summary This study introduces air pollution levels as an indicator for a region’s vulnerability to COVID-19 and suggests human-mobility reduction measures.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Dr Manu Sasidharan’s time on this research at the University of Cambridge was funded by the Engineering and Physical Science Research Council (EPSRC) through the grant EP/N021614/1 (CSIC Innovation and Knowledge Centre Phase 2) and Innovate UK through the grant 920035 (Centre for Smart Infrastructure and Construction). Dr Mehran Eskandari Torbagahan’s time on this research at the University of Birmingham was funded by EPSRC through the grant EP/N010523/1 (Balancing the Impact of City Infrastructure Engineering on Natural Systems using Robots).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes